4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-452004
Chief Scientific Officer sold 4,000 shares at $12.36 ($49,440)
- Chief Scientific Officer acquired 3,805 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Michaelson Jennifer Chief Scientific Officer | 2026-11-05 | Option exercise 10b5-1 | +3,805 | $4.30 | $16,362 | 162,649 | D |
| Michaelson Jennifer Chief Scientific Officer | 2026-11-05 | Sale 10b5-1 | −4,000 | $12.36 | $49,440 | 158,649 | D |
| Derivatives | |||||||
| Michaelson Jennifer Chief Scientific Officer | 2026-11-05 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,805 | 75,182 | D | ||
| Open-market sales · 4,000 sh · avg $12.36 · $49,440 | |||||||
Loading xslF345X06/ownership.xml…